Effects of age on multidrug resistance protein expression and doxorubicin accumulation in cardiac and skeletal muscle

References

• Ascensao A, Oliveira PJ, Magalhaes J. (2012). Exercise as a beneficial adjunct therapy during Doxorubicin treatment – role of mitochondria in cardioprotection. Int J Cardiol 156:4–10
   PubMed Web of Science ®Google Scholar
• Aslesen R, Engebretsen EM, Franch J, Jensen J. (2001). Glucose uptake and metabolic stress in rat muscles stimulated electrically with different protocols. J Appl Physiol 91:1237–44
   PubMed Web of Science ®Google Scholar
• Belinsky MG, Chen ZS, Shchaveleva I, et al. (2002). Characterization of the drug resistance and transport properties of multidrug resistance protein 6 (MRP6, ABCC6). Cancer Res 62:6172–7
   PubMed Web of Science ®Google Scholar
• Chen MH, Colan SD, Diller L. (2011). Cardiovascular disease: cause of morbidity and mortality in adult survivors of childhood cancers. Circ Res 108:619–28
   PubMed Web of Science ®Google Scholar
• Chu XY, Kato Y, Niinuma K, et al. (1997). Multispecific organic anion transporter is responsible for the biliary excretion of the camptothecin derivative irinotecan and its metabolites in rats. J Pharmacol Exp Ther 281:304–14
   PubMed Web of Science ®Google Scholar
• Chu XY, Strauss JR, Mariano MA, et al. (2006). Characterization of mice lacking the multidrug resistance protein MRP2 (ABCC2). J Pharmacol Exp Ther 317:579–89
   PubMed Web of Science ®Google Scholar
• Cui Y, Konig J, Buchholz JK, et al. (1999). Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells. Mol Pharmacol 55:929–37
   PubMed Web of Science ®Google Scholar
• Deeley RG, Westlake C, Cole SP. (2006). Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins. Physiol Rev 86:849–99
   PubMed Web of Science ®Google Scholar
• Evers R, de Haas M, Sparidans R, et al. (2000). Vinblastine and sulfinpyrazone export by the multidrug resistance protein MRP2 is associated with glutathione export. Br J Cancer 83:375–83
   PubMed Web of Science ®Google Scholar
• Gibson NM, Greufe SE, Schneider CM, Hayward R. (2012). Time course of doxorubicin accumulation and dysfunction in left ventricular tissue. Med Sci Sport Exerc 44:S139
   Web of Science ®Google Scholar
• Gilbert CM, Filippich LJ, McGeary RP, Charles BG. (2007). Toxicokinetics of the active doxorubicin metabolite, doxorubicinol, in sulphur-crested cockatoos (Cacatua galerita). Res Vet Sci 83:123–9
   PubMed Web of Science ®Google Scholar
• Gilliam LA, St Clair DK. (2011). Chemotherapy-induced weakness and fatigue in skeletal muscle: the role of oxidative stress. Antioxid Redox Signal 15:2543–63
   PubMed Web of Science ®Google Scholar
• Hayward R, Hydock D, Gibson N, et al. (2013a). Tissue retention of doxorubicin and its effects on cardiac, smooth, and skeletal muscle function. J Physiol Biochem 69:177–87
   PubMed Web of Science ®Google Scholar
• Hayward R, Iwaniec UT, Turner RT, et al. (2013b). Voluntary wheel running in growing rats does not protect against doxorubicin-induced osteopenia. J Pediatr Hematol Oncol 35:e144–8
   PubMed Web of Science ®Google Scholar
• He SM, Li R, Kanwar JR, Zhou SF. (2011). Structural and functional properties of human multidrug resistance protein 1 (MRP1/ABCC1). Curr Med Chem 18:439–81
   PubMed Web of Science ®Google Scholar
• Hopper-Borge E, Chen ZS, Shchaveleva I, et al. (2004). Analysis of the drug resistance profile of multidrug resistance protein 7 (ABCC10): resistance to docetaxel. Cancer Res 64:4927–30
   PubMed Web of Science ®Google Scholar
• Huang C, Zhang X, Ramil JM, et al. (2010). Juvenile exposure to anthracyclines impairs cardiac progenitor cell function and vascularization resulting in greater susceptibility to stress-induced myocardial injury in adult mice. Circulation 121:675–83
   PubMed Web of Science ®Google Scholar
• Huisman MT, Chhatta AA, van Tellingen O, et al. (2005). MRP2 (ABCC2) transports taxanes and confers paclitaxel resistance and both processes are stimulated by probenecid. Int J Cancer 116:824–9
   PubMed Web of Science ®Google Scholar
• Hydock DS, Lien CY, Jensen BT, et al. (2011). Characterization of the effect of in vivo doxorubicin treatment on skeletal muscle function in the rat. Anticancer Res 31:2023–8
   PubMed Web of Science ®Google Scholar
• Hydock DS, Wonders KY, Schneider CM, Hayward R. (2009). Voluntary wheel running in rats receiving doxorubicin: effects on running activity and cardiac myosin heavy chain. Anticancer Res 29:4401–7
   PubMed Web of Science ®Google Scholar
• Ilias A, Urban Z, Seidl TL, et al. (2002). Loss of ATP-dependent transport activity in pseudoxanthoma elasticum-associated mutants of human ABCC6 (MRP6). J Biol Chem 277:16860–7
   PubMed Web of Science ®Google Scholar
• Jungsuwadee P, Nithipongvanitch R, Chen Y, et al. (2009). Mrp1 localization and function in cardiac mitochondria after doxorubicin. Mol Pharmacol 75:1117–26
   PubMed Web of Science ®Google Scholar
• Kalyanaraman B, Joseph J, Kalivendi S, et al. (2002). Doxorubicin-induced apoptosis: implications in cardiotoxicity. Mol Cell Biochem 234–5:119–24
   Web of Science ®Google Scholar
• Kool M, de Haas M, Scheffer GL, et al. (1997). Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res 57:3537–47
   PubMed Web of Science ®Google Scholar
• Krause MS, Oliveira LP Jr, Silveira EM, et al. (2007). MRP1/GS-X pump ATPase expression: is this the explanation for the cytoprotection of the heart against oxidative stress-induced redox imbalance in comparison to skeletal muscle cells? Cell Biochem Funct 25:23–32
   PubMed Web of Science ®Google Scholar
• Lebrecht D, Geist A, Ketelsen UP, et al. (2007). Dexrazoxane prevents doxorubicin-induced long-term cardiotoxicity and protects myocardial mitochondria from genetic and functional lesions in rats. Br J Pharmacol 151:771–8
   PubMed Web of Science ®Google Scholar
• Leier I, Jedlitschky G, Buchholz U, et al. (1994). The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. J Biol Chem 269:27807–10
   PubMed Web of Science ®Google Scholar
• Lipshultz SE, Colan SD, Gelber RD, et al. (1991). Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med 324:808–15
   PubMed Web of Science ®Google Scholar
• Ma P, Dong X, Swadley CL, et al. (2009). Development of idarubicin and doxorubicin solid lipid nanoparticles to overcome Pgp-mediated multiple drug resistance in leukemia. J Biomed Nanotechnol 5:151–61
   PubMed Web of Science ®Google Scholar
• Martins RA, Minari AL, Chaves MD, et al. (2012). Exercise preconditioning modulates genotoxicity induced by doxorubicin in multiple organs of rats. Cell Biochem Funct 30:293–6
   PubMed Web of Science ®Google Scholar
• Minotti G, Recalcati S, Menna P, et al. (2004). Doxorubicin cardiotoxicity and the control of iron metabolism: quinone-dependent and independent mechanisms. Methods Enzymol 378:340–61
   PubMed Web of Science ®Google Scholar
• Mwale F, Marguier G, Ouellet JA, et al. (2008). Effect of dexrazoxane and amifostine on the vertebral bone quality of Doxorubicin treated male rats. Open Orthop J 2:115–20
   PubMedGoogle Scholar
• Naramoto H, Uematsu T, Uchihashi T, et al. (2007). Multidrug resistance-associated protein 7 expression is involved in cross-resistance to docetaxel in salivary gland adenocarcinoma cell lines. Int J Oncol 30:393–401
   PubMed Web of Science ®Google Scholar
• Olukman M, Can C, Erol A, et al. (2009). Reversal of doxorubicin-induced vascular dysfunction by resveratrol in rat thoracic aorta: is there a possible role of nitric oxide synthase inhibition? Anadolu kardiyoloji dergisi: AKD. Anatolian J Cardiol 9:260–6
   Web of Science ®Google Scholar
• Pereira GC, Pereira SP, Pereira CV, et al. (2012). Mitochondrionopathy phenotype in doxorubicin-treated Wistar rats depends on treatment protocol and is cardiac-specific. PloS One 7:e38867
   PubMed Web of Science ®Google Scholar
• Picard M, Csukly K, Robillard ME, et al. (2008). Resistance to Ca2+-induced opening of the permeability transition pore differs in mitochondria from glycolytic and oxidative muscles. Am J Physiol 295:R659–68
   Google Scholar
• Rose AJ, Alsted TJ, Jensen TE, et al. (2009). A Ca(2+)-calmodulin-eEF2K-eEF2 signalling cascade, but not AMPK, contributes to the suppression of skeletal muscle protein synthesis during contractions. J Physiol 587:1547–63
   PubMed Web of Science ®Google Scholar
• Sishi BJ, Loos B, van Rooyen J, Engelbrecht AM. (2013). Autophagy upregulation promotes survival and attenuates doxorubicin-induced cardiotoxicity. Biochem Pharmacol 85:124–34
   PubMed Web of Science ®Google Scholar
• Slot AJ, Molinski SV, Cole SP. (2011). Mammalian multidrug-resistance proteins (MRPs). Essays Biochem 50:179–207
   PubMed Web of Science ®Google Scholar
• Wijnholds J, Evers R, van Leusden MR, et al. (1997). Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein. Nat Med 3:1275–9
   PubMed Web of Science ®Google Scholar
• Yoshida M, Shiojima I, Ikeda H, Komuro I. (2009). Chronic doxorubicin cardiotoxicity is mediated by oxidative DNA damage-ATM-p53-apoptosis pathway and attenuated by pitavastatin through the inhibition of Rac1 activity. J Mol Cell Cardiol 47:698–705
   PubMed Web of Science ®Google Scholar
• Zhang DW, Cole SP, Deeley RG. (2001). Identification of an amino acid residue in multidrug resistance protein 1 critical for conferring resistance to anthracyclines. J Biol Chem 276:13231–9
   PubMed Web of Science ®Google Scholar
• Zhu W, Shou W, Payne RM, et al. (2008). A mouse model for juvenile doxorubicin-induced cardiac dysfunction. Pediatr Res 64:488–94
   PubMed Web of Science ®Google Scholar